Lumexa Imaging (NASDAQ:LMRI) Shares Down 5.8% – Time to Sell?

Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI) shares were down 5.8% on Monday . The stock traded as low as $7.99 and last traded at $8.0050. Approximately 572,659 shares changed hands during mid-day trading, a decline of 34% from the average daily volume of 865,049 shares. The stock had previously closed at $8.50.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on LMRI shares. Barclays reduced their target price on Lumexa Imaging from $15.00 to $9.00 and set an “overweight” rating for the company in a report on Wednesday, May 20th. Weiss Ratings upgraded Lumexa Imaging from a “sell (e-)” rating to a “sell (e)” rating in a report on Monday, June 1st. Finally, Raymond James Financial upgraded Lumexa Imaging from an “outperform” rating to a “strong-buy” rating and set a $23.00 target price for the company in a report on Monday, February 9th. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, Lumexa Imaging has an average rating of “Moderate Buy” and an average target price of $16.00.

Lumexa Imaging Price Performance

The business has a 50-day moving average of $8.78.

Insider Buying and Selling

In other Lumexa Imaging news, Director Brett Brodnax purchased 35,000 shares of the company’s stock in a transaction on Tuesday, May 19th. The shares were bought at an average cost of $7.25 per share, with a total value of $253,750.00. Following the transaction, the director directly owned 62,027 shares in the company, valued at approximately $449,695.75. This represents a 129.50% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 0.70% of the stock is currently owned by corporate insiders.

Institutional Trading of Lumexa Imaging

Institutional investors and hedge funds have recently modified their holdings of the company. Assetmark Inc. bought a new stake in shares of Lumexa Imaging during the fourth quarter valued at approximately $36,000. Strs Ohio bought a new stake in shares of Lumexa Imaging during the first quarter valued at approximately $38,000. PNC Financial Services Group Inc. bought a new stake in shares of Lumexa Imaging during the first quarter valued at approximately $63,000. State of Wyoming bought a new stake in shares of Lumexa Imaging during the first quarter valued at approximately $91,000. Finally, Barclays PLC bought a new stake in shares of Lumexa Imaging during the fourth quarter valued at approximately $133,000.

About Lumexa Imaging

We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2)across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).